0001493152-23-044868.txt : 20231214 0001493152-23-044868.hdr.sgml : 20231214 20231214163029 ACCESSION NUMBER: 0001493152-23-044868 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231214 FILED AS OF DATE: 20231214 DATE AS OF CHANGE: 20231214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intercure Ltd. CENTRAL INDEX KEY: 0001857030 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40614 FILM NUMBER: 231487443 BUSINESS ADDRESS: STREET 1: 85 MEDINAT HA-YEHUDIM STREET CITY: HERZLIYA STATE: L3 ZIP: 4676670 BUSINESS PHONE: 972774605012 MAIL ADDRESS: STREET 1: 85 MEDINAT HA-YEHUDIM STREET CITY: HERZLIYA STATE: L3 ZIP: 4676670 6-K 1 form6-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of December 2023

Commission File Number: 001-40614

INTERCURE LTD.

(Translation of registrant’s name into English)

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒

Form 40-F ☐

On December 14, 2023, an Annual General Meeting of Shareholders of Intercure Ltd. (the “Company”) approved each of the five proposals brought before the Company’s shareholders at the meeting, in accordance with the majority required for each proposal. Each of those proposals was described in the Company’s Notice and Proxy Statement with respect to the Company’s Annual General Meeting of Shareholders, dated November 8, 2023, attached as Exhibit 99.1 to the Company’s Form 6-K that was furnished to the U.S. Securities and Exchange Commission on November 8, 2023.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 14, 2023

	INTERCURE LTD.

	By:	/s/ Amos Cohen
		Amos Cohen
		Chief Financial Officer